Crossmark

Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking system

Published Online: 2026-04-12

Authors

Leung, Howell

Duan, Chengchen

Gou, Wenhao

Chen, Jianjiu

Xin, Ying

Zheng, Zetian

Naumov, Vladimir

Gennert, David

Zhang, Man

Aliper, Alex

Ren, Feng

Izumchenko, Evgeny

Pun, Frank W.

Zhavoronkov, Alex
License Information

Text and Data Mining valid from 2026-04-12

Accepted Manuscript valid from 2026-04-12
More Information

Article History

Received: 16 September 2025

Accepted: 2 April 2026

First Online: 12 April 2026

Declarations

:

: All authors except E.I are affiliated with Insilico Medicine: Insilico Medicine is a global clinical-stage commercial generative artificial intelligence company with several hundred patents, pending patent applications, and commercially available software.

Document is current